Journal of Diabetes and its Complications 2010-01-01

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression ofNɛ-carboxymethyl lysine

Toshihide Kawai, Izumi Takei, Mikiya Tokui, Osamu Funae, Kazunori Miyamoto, Mitsuhisa Tabata, Takumi Hirata, Takao Saruta, Akira Shimada, Hiroshi Itoh

文献索引：J. Diabetes Complications 24(6) , 424-32, (2010)

全文：HTML全文

摘要

Objective We investigated the efficacy of epalrestat, an aldose reductase inhibitor, for diabetic peripheral neuropathy in Japanese patients with type 2 diabetes.

结构式	名称/CAS号	分子式	全部文献
	依帕司他 CAS:82159-09-9	C₁₅H₁₃NO₃S₂

Inhibitor selectivity between aldo–keto reductase superfamil...
2013-11-15
[FEBS Lett. 587(22) , 3681-6, (2013)]

Docking and molecular dynamics studies toward the binding of...
2009-01-01
[J. Mol. Graph. Model. 28(2) , 162-9, (2009)]

6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reduct...
2010-10-01
[Bioorg. Med. Chem. Lett. 20 , 5630-3, (2010)]

Inhibitory activities of prenylated flavonoids from Sophora ...
2008-09-01
[J. Pharm. Pharmacol. 60(9) , 1227-36, (2008)]

Epalrestat. A review of its pharmacology, and therapeutic po...
1993-01-01
[Drugs Aging 3(6) , 532-55, (1993)]

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression ofNɛ-carboxymethyl lysine

摘要

相关化合物